AU720914B2 - Pharmaceutical tablet suitable to deliver the active substance in subsequent and preterminable times - Google Patents

Pharmaceutical tablet suitable to deliver the active substance in subsequent and preterminable times Download PDF

Info

Publication number
AU720914B2
AU720914B2 AU12526/97A AU1252697A AU720914B2 AU 720914 B2 AU720914 B2 AU 720914B2 AU 12526/97 A AU12526/97 A AU 12526/97A AU 1252697 A AU1252697 A AU 1252697A AU 720914 B2 AU720914 B2 AU 720914B2
Authority
AU
Australia
Prior art keywords
active substance
layer
tablet
granulate
core
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
AU12526/97A
Other languages
English (en)
Other versions
AU1252697A (en
Inventor
Ubaldo Conte
Lauretta Maggi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Jagotec AG
Original Assignee
Jagotec AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jagotec AG filed Critical Jagotec AG
Publication of AU1252697A publication Critical patent/AU1252697A/en
Application granted granted Critical
Publication of AU720914B2 publication Critical patent/AU720914B2/en
Anticipated expiration legal-status Critical
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cephalosporin Compounds (AREA)
AU12526/97A 1996-02-06 1997-02-04 Pharmaceutical tablet suitable to deliver the active substance in subsequent and preterminable times Expired AU720914B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ITMI96A000210 1996-02-06
IT96MI000210A IT1282576B1 (it) 1996-02-06 1996-02-06 Compressa farmaceutica atta a cedere la sostanza attiva in tempi successivi e predeterminabili

Publications (2)

Publication Number Publication Date
AU1252697A AU1252697A (en) 1997-08-28
AU720914B2 true AU720914B2 (en) 2000-06-15

Family

ID=11373151

Family Applications (1)

Application Number Title Priority Date Filing Date
AU12526/97A Expired AU720914B2 (en) 1996-02-06 1997-02-04 Pharmaceutical tablet suitable to deliver the active substance in subsequent and preterminable times

Country Status (10)

Country Link
US (1) US6294200B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
EP (1) EP0788790B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP (1) JPH09221416A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AT (1) ATE267007T1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU (1) AU720914B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CA (1) CA2196840C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE (1) DE69729134T2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DK (1) DK0788790T3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ES (1) ES2220999T3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IT (1) IT1282576B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (103)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030109503A1 (en) * 1995-06-06 2003-06-12 Smithkline Beecham P.L.C. Pharmaceutical formulations comprising clavulanic acid alone or in combination with other beta-lactam antibiotics
IT1295271B1 (it) * 1997-10-03 1999-05-04 Chiesi Farma Spa Monolita contenente uno o piu'farmaci costituito da tre strati a meccanismo di rilascio differenziato
KR100630290B1 (ko) * 1998-05-15 2006-09-29 쥬가이 세이야쿠 가부시키가이샤 방출제어제제
EP1005863A1 (en) * 1998-12-04 2000-06-07 Synthelabo Controlled-release dosage forms comprising a short acting hypnotic or a salt thereof
US6432448B1 (en) 1999-02-08 2002-08-13 Fmc Corporation Edible coating composition
US6723342B1 (en) 1999-02-08 2004-04-20 Fmc Corporation Edible coating composition
US6878386B1 (en) 1999-04-13 2005-04-12 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection comprising amoxycillin and potassium clavulanate
US6294199B1 (en) * 1999-04-13 2001-09-25 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection comprising administering amoxycillin
US7250176B1 (en) * 1999-04-13 2007-07-31 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection
DE19927688A1 (de) * 1999-06-17 2000-12-21 Gruenenthal Gmbh Mehrschichttablette zur Verabreichung einer fixen Kombination von Tramadol und Diclofenac
DE19954421A1 (de) * 1999-11-12 2001-05-31 Lohmann Therapie Syst Lts Filmförmige Zubereitung zur biphasigen Freisetzung pharmakologisch wirksamer oder anderer Substanzen
WO2001055293A2 (en) * 2000-01-25 2001-08-02 The Victoria University Of Manchester Delayed release of fluids
FR2805462B1 (fr) * 2000-02-24 2003-08-15 Therabel Res Nouvelle forme galenique orale a liberation prolongee de la molsidomine
AR030557A1 (es) 2000-04-14 2003-08-27 Jagotec Ag Una tableta en multicapa de liberacion controlada y metodo de tratamiento
US6756057B2 (en) 2000-10-12 2004-06-29 Beecham Pharmaceuticals (Pte) Limited Amoxicillin and potassium clavulanate dosage form
EP1330236A2 (en) 2000-10-12 2003-07-30 Beecham Pharmaceuticals (Pte) Limited Formulation containing amoxicillin
US6932861B2 (en) 2000-11-28 2005-08-23 Fmc Corporation Edible PGA coating composition
US6699315B2 (en) 2000-11-28 2004-03-02 Fmc Corporation Edible PGA coating composition
AU2008255254B2 (en) * 2001-03-31 2010-12-09 Jagotec Ag A pharmaceutical tablet system that floats on gastric fluid for multipulse release of active substance and respective processes of producing same and a cup-shaped envelope of same
EP1245227A1 (en) 2001-03-31 2002-10-02 Jagotec Ag A pharmaceutical tablet system that floats in the stomach for programmed release of active substance and process of producing buoyant material contained in same
US7211267B2 (en) 2001-04-05 2007-05-01 Collagenex Pharmaceuticals, Inc. Methods of treating acne
US20030070584A1 (en) 2001-05-15 2003-04-17 Cynthia Gulian Dip coating compositions containing cellulose ethers
US20040137062A1 (en) * 2001-05-25 2004-07-15 Sham Chopra Chronotherapy tablet and methods related thereto
IL159812A0 (en) * 2001-07-12 2004-06-20 Teva Pharma Dual release formulation comprising levodopa ethyl ester and a decarboxylase inhibitor in immediate release layer with levodopa ethyl ester in a controlled release core
IL159813A0 (en) * 2001-07-12 2004-06-20 Teva Pharma Dual release formulation comprising levodopa ethyl ester and a decarboxylase inhibitor in immediate release layer with levodopa ethyl ester and a decarboxylase inhibitor in a controlled release core
US8309118B2 (en) 2001-09-28 2012-11-13 Mcneil-Ppc, Inc. Film forming compositions containing sucralose
US7122143B2 (en) 2001-09-28 2006-10-17 Mcneil-Ppc, Inc. Methods for manufacturing dosage forms
US6982094B2 (en) 2001-09-28 2006-01-03 Mcneil-Ppc, Inc. Systems, methods and apparatuses for manufacturing dosage forms
US20040146559A1 (en) * 2002-09-28 2004-07-29 Sowden Harry S. Dosage forms having an inner core and outer shell with different shapes
US6837696B2 (en) * 2001-09-28 2005-01-04 Mcneil-Ppc, Inc. Apparatus for manufacturing dosage forms
US7838026B2 (en) 2001-09-28 2010-11-23 Mcneil-Ppc, Inc. Burst-release polymer composition and dosage forms comprising the same
US7323192B2 (en) 2001-09-28 2008-01-29 Mcneil-Ppc, Inc. Immediate release tablet
US7217381B2 (en) 2001-09-28 2007-05-15 Mcneil-Ppc, Inc. Systems, methods and apparatuses for manufacturing dosage forms
US20030228368A1 (en) * 2001-09-28 2003-12-11 David Wynn Edible solid composition and dosage form
ATE476957T1 (de) * 2001-09-28 2010-08-15 Mcneil Ppc Inc Pharmazeutische zusammensetzung auf fondantbasis
US7126786B1 (en) * 2001-10-01 2006-10-24 Certance Llc Motor/encoder assembly for tape drives
WO2003041646A2 (en) 2001-11-13 2003-05-22 Teva Pharmaceutical Industries, Ltd. L-dopa ethyl ester salts and uses thereof
AU2002346372A1 (en) * 2001-11-13 2003-05-26 Teva Pharmaceutical Industries, Ltd. Process for the production of l-dopa ethyl ester
ITMI20020514A1 (it) * 2002-03-12 2003-09-12 Jagotec Ag Sistema terapeutico per il rilascio controllato di uno o piu' principi attivi
US20060013875A1 (en) * 2002-05-29 2006-01-19 Impax Laboratories, Inc. Combination immediate release controlled release levodopa/carbidopa dosage forms
US7094427B2 (en) * 2002-05-29 2006-08-22 Impax Laboratories, Inc. Combination immediate release controlled release levodopa/carbidopa dosage forms
US20040166159A1 (en) * 2002-05-29 2004-08-26 Chien-Hsuan Han Pharmaceutical dosage forms having immediate and controlled release properties that contain an aromatic amino acid decarboxylase inhibitor and levodopa
US20030224045A1 (en) * 2002-05-29 2003-12-04 Chien-Hsuan Han Combination immediate release sustained release levodopa/carbidopa dosage forms
PL193976B1 (pl) * 2002-07-01 2007-04-30 Pliva Krakow Tabletka o przedłużonym działaniu zawierająca indapamid i sposób wytwarzania tabletki o przedłużonym działaniu zawierającej indapamid
US7429619B2 (en) 2002-08-02 2008-09-30 Mcneil Consumer Healthcare Polyacrylic film forming compositions
BR0314781A (pt) * 2002-09-28 2005-07-26 Mcneil Ppc Inc Composição de polìmero e formas de dosagem compreendendo a mesma
US20040081695A1 (en) * 2002-09-28 2004-04-29 Sowden Harry S Dosage forms having an inner core and an outer shell
US7807197B2 (en) * 2002-09-28 2010-10-05 Mcneil-Ppc, Inc. Composite dosage forms having an inlaid portion
EP1449525A1 (en) * 2003-02-20 2004-08-25 Cross Chem Llc chewing gum in the form of multi-layer tablets
CN1856299B (zh) * 2003-09-19 2013-09-04 太阳医药工业有限公司 口服药物释出系统
US10226428B2 (en) 2003-09-19 2019-03-12 Sun Pharma Advanced Research Company Ltd. Oral drug delivery system
US10213387B2 (en) 2003-09-19 2019-02-26 Sun Pharma Advanced Research Company Ltd. Oral drug delivery system
US20050201974A1 (en) * 2003-12-09 2005-09-15 Spherics, Inc. Bioadhesive polymers with catechol functionality
US8007827B2 (en) * 2004-04-02 2011-08-30 Impax Laboratories, Inc. Pharmaceutical dosage forms having immediate release and/or controlled release properties
WO2005107811A2 (en) * 2004-05-04 2005-11-17 Perry Victor A Drug delivery device
US7838031B2 (en) 2004-05-21 2010-11-23 Lawrence Solomon Method of administering a partial dose using a segmented pharmaceutical tablet
CA2564960A1 (en) * 2004-05-21 2005-12-01 Lawrence Solomon Pharmaceutical tablets having a separation mark positioned on the side of said tablets
US7713547B2 (en) 2004-05-21 2010-05-11 Accu-Break Pharmaceuticals, Inc. Method of administering a partial dose of a segmented pharmaceutical tablet
US7318935B2 (en) * 2004-05-21 2008-01-15 Accu-Break Technologies, Inc. Pharmaceutical tablets with active and inactive segments
US7622137B2 (en) * 2004-05-21 2009-11-24 Accu-Break Technologies, Inc. Dosage forms contained within a capsule or sachet
US7780985B2 (en) * 2005-07-12 2010-08-24 Accu-Break Technologies, Inc. Tablets having a printed separation mark to guide breaking
US7329418B2 (en) * 2004-05-21 2008-02-12 Accu Break Technologies, Inc. Pharmaceutical tablets having height greater than width
US20060002986A1 (en) * 2004-06-09 2006-01-05 Smithkline Beecham Corporation Pharmaceutical product
US20080311191A1 (en) * 2004-08-27 2008-12-18 Avinash Nangia Multi-Layer Tablets and Bioadhesive Dosage Forms
DE102004043863A1 (de) * 2004-09-10 2006-03-16 Nitec Pharma Ag Tabletten mit orts- und zeitgesteuerter Wirkstofffreisetzung im Gastrointestinum
CA2579732C (en) * 2004-09-10 2014-08-12 Nitec Pharma Ag Tablets with site time-controlled gastrointestinal release of active ingredient
JP5258297B2 (ja) * 2004-11-19 2013-08-07 グラクソスミスクライン・リミテッド・ライアビリティ・カンパニー 個人別に療法を合わせるために可変用量の薬物併用製品を特注で調剤する方法
US8673352B2 (en) 2005-04-15 2014-03-18 Mcneil-Ppc, Inc. Modified release dosage form
US20070148238A1 (en) * 2005-06-23 2007-06-28 Spherics, Inc. Dosage forms for movement disorder treatment
KR100714616B1 (ko) * 2005-06-23 2007-05-07 삼성전기주식회사 지수 함수 발생기 및 이를 이용한 가변 이득 증폭기
WO2007008305A1 (en) 2005-07-08 2007-01-18 Cherng-Ju Kim Asymmetrically coated tablet
AU2005338350A1 (en) * 2005-11-18 2007-05-24 Solapharm, Inc. Segmented pharmaceutical dosage forms
EP1970055B1 (en) * 2005-12-29 2010-11-24 Osmotica Kereskedelmi És Szolgáltató Kft Multi-layered tablet with triple release combination
EP2086515A2 (en) * 2006-03-02 2009-08-12 Vaunnex, Inc. Rate-controlled bioadhesive oral dosage formulations
US20070237815A1 (en) * 2006-04-06 2007-10-11 Lawrence Solomon Dosage forms and methods comprising amlodipine and chlorthalidone
US20070293587A1 (en) * 2006-05-23 2007-12-20 Haley Jeffrey T Combating sinus, throat, and blood infections with xylitol delivered in the mouth
WO2007139661A1 (en) * 2006-05-23 2007-12-06 Haley Jeffrey T Xylitol troches and methods of use
JP2009545546A (ja) 2006-08-03 2009-12-24 ニテック ファーマ アクチエンゲゼルシャフト リウマチ性疾患の遅延放出型グルココルチコイド治療
US20110086092A1 (en) * 2006-08-08 2011-04-14 Accu-Break Technologies, Inc. Pharmacuetical tablets containing a plurality of active ingredients
WO2008025532A1 (en) * 2006-08-30 2008-03-06 Jagotec Ag Controlled release solid oral dosage formulations comprising nisoldipine
US20100316712A1 (en) * 2006-12-22 2010-12-16 Combinatorx, Incorporated Pharmaceutical compositions for treatment of parkinson's disease and related disorders
WO2008142627A2 (en) * 2007-05-17 2008-11-27 Ranbaxy Laboratories Limited Multilayered modified release formulation comprising amoxicillin and clavulanate
US8513323B2 (en) * 2007-06-22 2013-08-20 Kimbery-Clark Worldwide, Inc. Multifunctional silicone blends
US10736850B2 (en) * 2007-08-13 2020-08-11 Ohemo Life Sciences Inc. Abuse resistant oral opioid formulations
JP5783725B2 (ja) 2007-12-28 2015-09-24 インパックス ラボラトリーズ、 インコーポレイテッドＩｍｐａｘ Ｌａｂｏｒａｔｏｒｉｅｓ， Ｉｎｃ． レボドパの放出制御製剤及びその使用
MX2010008861A (es) * 2008-02-15 2011-02-22 Sun Pharma Advanced Res Co Ltd Tableta oral de liberacion controlada con efecto de liberacion masiva reducido.
JP2012500221A (ja) 2008-08-15 2012-01-05 ディポメド，インコーポレイティド Ｃｎｓ障害の処理及び予防のための胃保持性医薬組成物
AU2010206706C1 (en) 2009-01-22 2015-09-10 Intercontinental Great Brands Llc Confectionery processing
MX2012004126A (es) * 2009-10-08 2012-07-20 Kraft Foods Global Brands Llc Metodos y aparato para goma y caramelo en capas co-extrudido.
EP2509587A2 (en) 2009-12-07 2012-10-17 McNeil-PPC, Inc. Partial dip coating of dosage forms for modified release
WO2011078993A1 (en) 2009-12-21 2011-06-30 Aptapharma, Inc. Functionally-coated multilayer tablets
EP2550961A4 (en) * 2010-03-23 2013-08-07 Lintec Corp SOLID PREPARATION
CA2924722A1 (en) * 2013-09-27 2015-04-02 Johnson & Johnson Consumer Inc. Compression coated pulsatile release compositions
US10987313B2 (en) 2013-10-07 2021-04-27 Impax Laboratories, Llc Muco-adhesive, controlled release formulations of levodopa and/or esters of levodopa and uses thereof
US10098845B2 (en) 2013-10-07 2018-10-16 Impax Laboratories, Llc Muco-adhesive, controlled release formulations of levodopa and/or esters of levodopa and uses thereof
CN103948557A (zh) * 2014-04-08 2014-07-30 闻晓光 一种新型控释片
WO2016192680A1 (en) 2015-06-03 2016-12-08 Triastek, Inc. Dosage forms and use thereof
AU2017261372B2 (en) * 2016-05-05 2019-02-14 Triastek, Inc. Controlled release dosage form
CA3051614A1 (en) 2017-01-26 2018-08-02 Triastek, Inc. Dosage forms of controlled release at specific gastrointestinal sites
JP7040418B2 (ja) * 2018-11-21 2022-03-23 株式会社村田製作所 錠剤
US20220071909A1 (en) * 2020-08-26 2022-03-10 Rubicon Research Private Limited Modified release formulations of levodopa
US11986449B2 (en) 2020-12-22 2024-05-21 Amneal Pharmaceuticals Llc Levodopa dosing regimen
WO2022140448A1 (en) 2020-12-22 2022-06-30 Amneal Pharmaceuticals Llc Levodopa dosing regimen

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4865849A (en) * 1987-01-13 1989-09-12 Pharmidea Tablet for pharmaceutical use able to release active substances at successive times
US5213808A (en) * 1989-09-22 1993-05-25 Buhk Meditec A/A Controlled release article with pulsatile release
US5487901A (en) * 1993-05-31 1996-01-30 Ekita Investments N.V. Process for preparing pharmaceutical tablet capable of releasing the active ingredients contained therein at subsequent times

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1022171A (en) 1961-06-15 1966-03-09 Wellcome Found Prolonged release oral pharmaceutical tablets and their manufacture
FR2100858B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1970-07-03 1975-06-06 Daiichi Seiyaku Co
US4077407A (en) 1975-11-24 1978-03-07 Alza Corporation Osmotic devices having composite walls
US4898733A (en) * 1985-11-04 1990-02-06 International Minerals & Chemical Corp. Layered, compression molded device for the sustained release of a beneficial agent
IT1255522B (it) * 1992-09-24 1995-11-09 Ubaldo Conte Compressa per impiego terapeutico atta a cedere una o piu' sostanze attive con differenti velocita'
EP0724441A1 (en) * 1993-10-19 1996-08-07 The Procter & Gamble Company Picosulphate dosage form

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4865849A (en) * 1987-01-13 1989-09-12 Pharmidea Tablet for pharmaceutical use able to release active substances at successive times
US5213808A (en) * 1989-09-22 1993-05-25 Buhk Meditec A/A Controlled release article with pulsatile release
US5487901A (en) * 1993-05-31 1996-01-30 Ekita Investments N.V. Process for preparing pharmaceutical tablet capable of releasing the active ingredients contained therein at subsequent times

Also Published As

Publication number Publication date
DE69729134T2 (de) 2005-05-12
US6294200B1 (en) 2001-09-25
JPH09221416A (ja) 1997-08-26
ITMI960210A1 (it) 1997-08-06
ITMI960210A0 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1996-02-06
EP0788790A3 (en) 1998-11-04
CA2196840C (en) 2001-12-04
CA2196840A1 (en) 1997-08-07
ATE267007T1 (de) 2004-06-15
ES2220999T3 (es) 2004-12-16
EP0788790B1 (en) 2004-05-19
IT1282576B1 (it) 1998-03-31
DK0788790T3 (da) 2004-09-20
DE69729134D1 (de) 2004-06-24
EP0788790A2 (en) 1997-08-13
AU1252697A (en) 1997-08-28

Similar Documents

Publication Publication Date Title
AU720914B2 (en) Pharmaceutical tablet suitable to deliver the active substance in subsequent and preterminable times
US5738874A (en) Pharmaceutical tablet capable of liberating one or more drugs at different release rates
US6183778B1 (en) Pharmaceutical tablet capable of liberating one or more drugs at different release rates
US5487901A (en) Process for preparing pharmaceutical tablet capable of releasing the active ingredients contained therein at subsequent times
EP0656204B1 (en) Controlled release pharmaceutical tablet having lenticular form
US6027748A (en) Pharmaceutical tablet, completely coated, for controlled release of active principles that present problems of bio-availability linked to gastro-intestinal absorption
US5681583A (en) Multilayered controlled-release oral solid pharmaceutical forms
JP4664595B2 (ja) 活性成分の放出を制御する治療システム
IL131292A (en) Pharmaceutical preparations for controlled release of active ingredients
AU2005201805A1 (en) Hydrophilic / lipophilic polymeric matrix dosage formulation
CA2554012A1 (en) Oral dosage formulation
CA2739751A1 (en) Pharmaceutical compositions comprising hydromorphone and naloxone
JP2005524670A (ja) 放出制御投与形態
MX2007001058A (es) Formas de dosificacion con tableta nucleo recubierta entericamente.
NZ314181A (en) Medicinal tablet having 2 or 3 partially coated core layers for controlled release of actives
CN101453990B (zh) 丁氨苯丙酮可控释放配方及其制造方法
CN1488332A (zh) 脉冲释放的口服制剂及制备方法
CA2124425C (en) Pharmaceutical tablets releasing the active substance after a definite period of time
MXPA99008148A (en) Pharmaceutical compositions for controlled release of active substances
HK1127564A (en) Oral controlled release formulation for sedative and hypnotic agents

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)
DA3 Amendments made section 104

Free format text: THE NATURE OF THE AMENDMENT IS: AMEND THE TITLE OF THE INVENTION TO READ PHARMACEUTICAL TABLET SUITABLE TO DELIVER THE ACTIVE SUBSTANCE IN SUBSEQUENT AND PREDETERMINABLE TIMES